BCL2 and Alzheimer disease: In our study, FGF10 treatment decreased the activity of apoptosis regulators cytochrome c and caspase‐3, and slightly increased the ratio of Bcl‐2 to Bax in the cortices and hippocampi of 3xTg‐AD mice and in APPswe transfected HT22 cells.